Invasion, cell proliferation and apoptosis are important biological features of neoplasia, bearing prognostic importance. Histological stage, mitotic index, and apoptotic index have been assessed in 33 feline malignant mammary tumors. Histological stage (P Ͻ 0.01) and mitotic index (P Ͻ 0.001) had a significant association with prognosis in univariate analysis. Apoptotic index did not correlate with survival (P ϭ 0.44), and histological stage (P ϭ 0.48) did not correlate with mitotic index (P ϭ 0.39). In feline malignant mammary tumors the apoptotic index seems unable to predict survival and lacks any correlation with proliferation assessed as mitotic index. A possible explanation for the lack of correlation between apoptotic index and survival may be due to the rapid acquisition of pathways of apoptosis resistance in feline mammary tumors or to rapid hormone receptors loss.
Increased proliferative activity and resistance to apoptosis are known phenomena in tumors. 18, 32, 37 A perturbation in the balance between mitosis and apoptosis may contribute to the development of neoplasia. 30 Growth fraction is important for the assessment of the mass increase of a tumor and is dependent both on the number of cells produced (also defined as proliferative fraction) and the extent of cell loss. 27, 37 Cell loss follows different pathways, such as the migration of the cells from the tumor, the differentiation of the cells, and cell death due to necrosis or apoptosis. 27 In rodent models of mammary tumorigenesis, excessive cell proliferation permits the accumulation of mutations that contribute to the subsequent development of mammary tumors. 25 Inhibition of apoptosis prolongs cell life, allowing the accumulation of mutations necessary for neoplastic transformation. 1 Recent findings on human breast cancer support positive relationships between cell proliferation or tumor grade and apoptosis. 5, 20 Among the techniques employed to assess cell proliferation in tumors, 14, 37 quantitative evaluation of both Ki67 and argyrophilic proteins associated with nucleolar organizer regions (AgNOR) in feline mammary tumors is reported to be useful prognostic factors. 7, 8, 28 Little information is available regarding the role of apoptosis with respect to both the progression from noninfiltrating to infiltrating tumors, and prognosis. 12, 22, 27 The aim of this study was to investigate the role of apoptosis in feline mammary tumors and its relation- ship with invasiveness (histological stage) and cell proliferation assessed by mitotic index.
Materials and methods
Material. Thirty-three tissue samples were selected from female cats with malignant primary mammary tumors. All the cats underwent surgery at the University Clinic of Veterinary Surgery (Bologna, Italy) and in private clinics between 1992 and 1997.
Thoracic radiographs and ultrasonograms of the spleen, liver, and kidneys were taken before surgery and every 2 mo over a 2-yr period. None of the cats had distant metastases (M0) at surgery, and follow-up data were collected over this period and expressed as survival time (the time between surgery and death due to the tumor, irrespective of death being spontaneous or by euthanasia). The analyzed data refer to a time period of 24 mo for the queens that survived for more than 2 yr (assessed cases) or the exact number of months between surgery and death (nonassessed cases).
The tumors were immediately fixed in 10% buffered formalin and routinely processed. Histopathologic diagnoses were performed on hematoxylin-eosin-stained slides according to a published method, 24 and histologic grade of invasion was assessed according to a system previously proposed 13 and then adapted to the cat 23 as follows: stage 0, noninfiltrating malignant tumors; stage I, malignant tumors with stromal invasion; stage II, malignant tumors with neoplastic emboli in vessels and/or regional lymph node involvement.
Toluidine blue stain for mitosis. One of two 4--thick sections for each case was dewaxed, rehydrated, and then hydrolyzed in 5 N HCl for 20 min at room temperature (RT), rinsed twice (5 min each) in distilled water (DW), and immersed for 10 min in a solution prepared with 0.5 g toluidine blue O in 100 ml of bleach solution (90 ml of twice DW, 5 ml 1 N HCl, 5 ml 10% sodium metabisulphite). The sections were then immersed twice (1 min each) in bleach solution, Terminal Deoxynucleotidyl Transferase-Mediated dUTP Nick End Labeling (TUNEL) for apoptosis. One of two 4thick sections was stained with a commercial apoptosis kit. a The kit utilizes reagents for nonisotopic deoxyribonucleic acid (DNA) end-extension in situ (digoxigenin-11-dUTP), and other reagents for immunohistochemical staining (antidigoxigenin peroxidate antibody) of the extended DNA. Residues of digoxigenin-nucleotide are catalytically added to the DNA by terminal deoxynucleotidyl transferase (TdT) which generates, to the 3Ј-OH ends of double or single-stranded DNA, tails of digoxigenin d-UTP, revealed immunohistochemically by the anti-digoxigenin antibody.
Sections were dewaxed, rehydrated, and then treated with Proteinase K, b 0.002 g in 100 ml Tris/HCl buffer (0.15 M, pH 7.6), for 15 min at RT. Sections were washed in DW, and endogenous peroxidase was blocked by means of 3% hydrogen peroxide in Tris/HCl buffer for 5 min at RT. After these washes, sections were allowed to react with the equilibration buffer from the kit for 30 min at RT, with TdTenzyme solution for 60 min at 37 C, and then with stop/ wash solution for 30 min at 37 C, followed by washes in Tris buffer. Sections were finally allowed to react with the anti-digoxigenin peroxidate antibody for 30 min at RT in a humid chamber. After washes in Tris/HCl buffer, the reaction was developed in a solution of 0.04% diaminobenzidine containing 0.04% hydrogen peroxide for 6 min at RT. Sections were then counterstained with Mayer hematoxylin for 10 sec, dehydrated, and mounted in DPX. In control slides TdTenzyme solution was substituted by DW.
Scoring method. Quantitative analysis was performed with a computer-assisted image analyzer equipped with a specific morphometric software. c Mitoses and apoptosis were scored by 2 different individuals.
Mitotic index. For each case, the observer selected 10 fields in the most mitotically active areas of the section using a 25ϫ objective and a 10ϫ eyepiece yielding a final magnification of 250ϫ. In each field inflammatory or stromal cells were manually erased with the mouse of the computer, and using a red (630/10) band-pass filter, the total nuclear area of only the neoplastic cells was mapped, and the number of mitoses was counted. The total number of cells in the 10 fields was assessed dividing the total nuclear area of the fields by the mean area of a nucleus. Mitotic index was expressed as the number of mitoses per 100 neoplastic cells (mitotic index ϭ total number of mitoses in 10 fields/total number of cells in 10 fields ϫ 100).
Apoptotic index. Ten fields were chosen using a 40ϫ objective and a 10ϫ eyepiece, yielding a final magnification of 400ϫ (high power field or hpf). In each field the number of apoptotic nuclei and/or apoptotic bodies, the total nuclear area, and the mean area of a nucleus were evaluated. To compare apoptosis quantitation among tumors characterized by different cellularity and to avoid the variability of hpf from microscope to microscope, apoptosis has been expressed as the number of positive nuclei per 100 cells. This ratio was referred to as apoptotic index and was calculated as follows: apoptotic index ϭ total number of apoptoses/ apoptotic bodies in 10 fields/total number of cells in 10 fields ϫ 100.
Statistical analysis. Statistical analyses were performed as previously described 6 using a software package. d Mitotic index and apoptotic index were tested for normality with Shapiro-Wilk's W-test. As no significant results were obtained for both parameters analyzed using this test, all the variables were considered normally distributed, allowing employment of analysis of variance (ANOVA) for comparison among groups. One-way ANOVA was performed to compare the mitotic or the apoptotic indices among groups with different histological stages. According to the median values of indices, cases were divided into low and high proliferative/apoptotic activity groups, and their survival curves were computed using the Kaplan-Meier estimate and compared by survival analysis. A conventional 5% level was used to define statistical significance. 
Results
The age of the cats ranged from 5 to 17 years (mean Ϯ SD 10.95 Ϯ 3.03); breeds included 24 shorthaired cats, 4 Persian cats, and 5 Siamese cats; and the diagnoses included 12 (36.36%) tubular adenocarcinomas, 12 (36.36%) solid carcinomas, 7 (21.22%) papillary-cystic carcinomas, 1 (3.03%) mucinous carcinoma, and 1 (3.03%) scirrhous carcinoma. After 24 months from surgery 13 cats (39.4%) were alive, and 20 (60.6%) had died.
Out of the 33 cases, 3 were graded as stage 0, 12 as stage I, and 18 as stage II. Survival analysis revealed a significant difference in outcome among the 3 histological stages (P Ͻ 0.01) ( Fig. 1) . All 3 stage 0 cases were alive after 24 months; stage I and stage II tumors had survival times (mean Ϯ SD) of 21.83 Ϯ 7.83 and 13.38 Ϯ 8.99 months, respectively.
Apoptotic cells/bodies stained brown, and various morphological phases of apoptosis were present (Figs. 2 and 3). Chromatin margination ( Fig. 3b ) and nuclear condensation (Fig. 3b) were the morphologic features of apoptosis in identifiable single cells. Apoptotic bodies ( Fig. 3d ) were mainly localized in the interstitial space. Other nuclei did not appear condensed but stained uniformly (Fig. 3e, 3f) , representing a phase earlier than chromatin margination and were revealed because of the amplification of DNA fragmentation.
The apoptotic signal in viable tumor parenchyma appeared scattered without background staining. Background staining was present only in necrotic areas.
Of the 33 selected tumors, 29 showed a positive reaction to the TUNEL staining method. Descriptive statistical data of apoptotic index were median, 1.63; mean Ϯ SD, 1.72 Ϯ 0.46; and range, 0.88-2.87. Regression analysis between apoptotic index as dependent variable and mitotic index as independent variable had no significant correlation among the compared variables (R ϭ 0.10, P ϭ 0.57) (Fig. 4A ). Similar results were obtained by one-way ANOVA, which showed no differences in apoptotic index of cases grouped according to histological stage ( Fig. 4B ) (P ϭ 0.48). To test the prognostic role of apoptotic index, values were divided according to the median value into low and high apoptotic activity groups; values were then compared by survival analysis, which did not reveal any prognostic value for apoptotic index (P ϭ 0.44) (Fig. 4C) .
Mitotic figures were easily recognized with toluidine blue stain (Fig. 5 ). Descriptive statistical data of mitotic index were median, 0.72; mean Ϯ SD, 0.71 Ϯ 0.52; and range, 0.07-2.44. One-way ANOVA revealed a significant difference in mitotic index among cases grouped according to histological stage (P Ͻ 0.05, Fig. 6A ). A significant difference in outcome by survival analysis was shown between cases grouped according to low (mitotic index lower than its median value) or high (value above median) proliferative activity (P Ͻ 0.001) (Fig. 6B ).
Discussion
In the female cat, mammary tumors are the third most common neoplasia after cutaneous and hematopoietic tumors. 11 Feline mammary neoplasms are usually malignant and progress rapidly. 35, 36 Several parameters are considered important prognostic indicators for these neoplasms, such as age, size of the primary tumor, lymph node involvement, number of mitoses, extent of necrosis, completeness of surgical resection, and type of invasion. 16, 21, 28, 36 Recently, the use of some selected proliferative indices, 7, 8, 10, 12, 29 such as AgNOR protein quantitation, mitotic index, and immunohistochemical detection of cell-cycle-associated antigens (PCNA, Ki-67), has been proposed for diagnostic and prognostic purposes. Caution is necessary when evaluating the role of proliferative indices because of the contradictory information in the literature. However, most authors regard proliferative indices as useful prognostic indicators because they provide information independent of histological and clinical variables. 8, 29 It has been recently pointed out that the magnitude of cell turnover is due to both proliferation and loss of cells. 33 In tumors, phenomena responsible for cell loss are apoptosis and necrosis, which coexist but are the result of different mechanisms: necrosis is a passive event due to an external injurious agent, whereas apoptosis is an actively regulated event triggered in the cell. 32 It is now known that apoptosis in tumors can be triggered by mild ischemia, cytokines such as tumor necrosis factor, cytotoxic T-lymphocytes, chemotherapeutic agents, radiation, and growth hormone withdrawal. 18 However, neoplastic cells can up-regulate some mechanisms involved in resistance to apoptosis (p53 mutations; bcl-2 up-regulation), leading to the accumulation of cells 18, 32 which favors tumor progression. In this way a reduction of cell loss, in ad-dition to cell proliferation, can account for cell accumulation in tumors. Apoptosis has been considered to have a critical role in the growth of various neoplasms because the rate of tumor growth depends on the balance between the proliferative fraction and the spontaneous (apoptotic) loss of the tumor cell population. 19 Invasiveness, as determined by histological stage, revealed a significant prognostic variable. Similar results have been obtained from other clinical trials. 3, 28 Furthermore, invasiveness was shown to be similar in predicting survival to proliferation (mitotic index). This enhances the role of histological grading of the tumor over other more sophisticated methods to predict prognosis.
Toluidine blue and other thiazine dyes have high affinity for nuclei with condensed chromatin. This allows an easier identification of mitotic figures. 9 The ability of thiazines to be employed as Schiff-type reagents for the staining of DNA and carbohydrates has been previously described. 4, 9, 34 Quantitative evaluation of mitotic activity using an image analyzer is a rapid method of expressing mitoses per cell number (i.e., mitotic index), if combined with a stain such as toluidine blue, which has the advantage of staining neither the cytoplasm nor the stroma but only the nuclei. 3 Apoptosis determination in neoplasms is usually accomplished by 2 methods: morphologic detection of apoptotic bodies by light microscopy and in situ 3Јend labelling. The former has the lower sensitivity because morphological manifestations of apoptosis, such as nuclear shrinkage, are of very short duration or are difficult to detect. 32 The in situ 3Ј-end labelling can be performed using 2 different methods. In the first, DNA polymerase is used to incorporate labelled nucleotides into fragmented DNA by in situ nick translation, whereas in TUNEL, terminal transferase is used to add labelled nucleotides into the 3Ј-end of the DNA. 26 TU-NEL is considered more sensitive than in situ nick translation, and in investigations on clinical tumor material, the TUNEL technique has almost exclusively been used. 32 In this study, the results of survival analysis support the value of histological staging in predicting postsurgical outcome in feline mammary carcinomas. On the basis of the mean values of mitotic index, a significant difference in proliferation was observed among the different histologic stages; these results suggest a close relationship between the growth fraction expressed by the mitotic index and the infiltrative growth graded as histologic stage. Moreover, a prognostic relevance was revealed by the mitotic index, which showed significantly different survival curves comparing cases with low and high proliferative activity. On the contrary, the apoptotic index showed neither correlation with histologic invasiveness nor difference in clinical out- come between high and low apoptotic activity groups. According to these data, in feline malignant mammary tumors apoptosis does not seem to play any important role in tumor progression because it remains unaffected by the acquisition of an invasive behavior or by the increase in proliferative activity. In human breast carcinomas, instead, a close relationship has been reported between apoptosis, cell proliferation, and poor prognosis. 5, 20 This is probably due to the loss of a hormone (progesterone and estrogens) receptor that acts as a survival factor. 31 In human breast cancer, hormone dependence is lost late in cancerogenesis; in fact, lowgrade malignant tumors, as well as hormone receptors, show upregulation of the bcl-2 antiapoptotic oncogene. 2, 17 In feline mammary tumors, instead, hormone receptors are lost very early during cancerogenesis. 15 Therefore, due to the early reduction of hormone receptors in feline mammary tumors, hormone withdrawal does not seem to play an important role in triggering apoptosis. So the amount of apoptosis scored is likely to reflect a stochastic event and not an aspect strictly linked to any precise moment of cell progression. For this reason, probably apoptotic index is unable to give useful prognostic indications.
In feline malignant mammary tumors, the importance of apoptosis seems irrelevant compared with proliferation in tumor progression. Therefore, in clinical trials the use of antiproliferative drugs seems to be more consistent than that of apoptosis-stimulating drugs. 
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